Argitalpenak (12) Ikertzaileren baten partaidetza izan duten argitalpenak

2013

  1. Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study

    British Journal of Cancer, Vol. 109, Núm. 1, pp. 121-130

  2. Complications of kidney transplantation with grafts from expanded criteria donors

    World Journal of Urology, Vol. 31, Núm. 4, pp. 893-899

  3. Estudio comparativo de morbimortalidad entre conducto ileal y ureterosigmoidostomía tras cistectomía radical por neoplasia vesical

    Actas Urologicas Espanolas, Vol. 37, Núm. 10, pp. 613-618

  4. Métastase pancréatique métachrone du cancer du rein: À propos d'un cas

    Journal of the Canadian Urological Association, Vol. 7, Núm. 5-6 JUN

  5. Prostate adenocarcinoma. Predictive clinical model of seminal vesicle involvement

    Archivos Espanoles de Urologia, Vol. 66, Núm. 6, pp. 576-583

  6. Radical prostatectomy. Prognostic value of positive surgical margins in PT2 patients

    Archivos Espanoles de Urologia, Vol. 66, Núm. 8, pp. 796-806

  7. Recipient and donor risk factors for surgical complications following kidney transplantation

    Scandinavian Journal of Urology, Vol. 47, Núm. 1, pp. 63-71

  8. Reparación de fístula urinaria en injerto renal mediante nefrectomía parcial y omentoplastia

    Actas Urologicas Espanolas, Vol. 37, Núm. 5, pp. 316-320

  9. Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology

    Actas Urologicas Espanolas

  10. Ureteroiliac fistula secondary to radiotherapy in a patient with single renal metastasis of colon adenocarcinoma

    Journal of the Canadian Urological Association, Vol. 7, Núm. 2

  11. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572

  12. Variante plasmocitoide del carcinoma urotelial: a propósito de un caso

    Anales del sistema sanitario de Navarra, Vol. 36, Núm. 2, pp. 357-361